Related Experiment Video
Updated: Jun 27, 2025
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.3K
Correlation between SUA and prognosis in CHF patients after revascularization
Bo Miao1, Jing Wu2, Wang Jiao1
1Xingtai Third Hospital, Cardiovascular Intensive Care Unit, Xingtai, China.
Journal of Medical Biochemistry
|May 3, 2024
Summary
Serum uric acid (SUA) levels correlate with prognosis in chronic heart failure (CHF) patients post-revascularization. Higher SUA indicates poorer outcomes, suggesting its potential as a prognostic marker in heart failure management.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Chronic heart failure (CHF) poses a significant clinical challenge.
- Revascularization procedures like PCI and CABG are common treatments for CHF.
- The prognostic role of serum uric acid (SUA) in CHF post-revascularization requires further elucidation.
Purpose of the Study:
- To investigate the association between serum uric acid (SUA) levels and prognosis in patients with chronic heart failure (CHF) following revascularization.
- To analyze the correlation of SUA with inflammatory markers and cardiac function in CHF patients.
Main Methods:
- A cohort of 126 CHF patients undergoing revascularization (PCI or CABG) and 126 healthy controls were studied.
- Serum uric acid, inflammatory factors, and cardiac function were measured.
- Patients were followed for 6 months to assess prognosis, with statistical analyses including logistic regression and ROC curves.
Main Results:
- Serum uric acid levels were compared between CHF patients and healthy controls.
- Correlations between SUA, inflammatory markers, and cardiac function were analyzed.
- Differences in SUA levels were observed among patients with varying prognoses, and risk factors were identified.
Conclusions:
- Serum uric acid levels are associated with prognosis in chronic heart failure patients after revascularization.
- SUA may serve as a valuable predictive biomarker for outcomes in CHF patients undergoing revascularization.
More Related Videos
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
81
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
01:17Factors Affecting Renal Clearance: Renal Impairment
91
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91